Tscan Therapeutics, Inc. Announced That The U.S. Food And Drug Administration (Fda) Has Cleared Its Investigational New Drug (Ind) Applications For T-Plex, Tsc-204-A0201, And Tsc-204-C0702. T-Plex Serves As The Primary Ind For Tscan
Found this useful? Share it with your team.
